The value of BMT in AML patients in first remission A statistician's view-point Stefan Suciu Editorial Pages: 41 - 44
Analysis of CD34-positive hemopoietic progenitor cells from normal human adult peripheral blood: flow-cytometrical studies and in-vitro colony (CFU-GM, BFU-E) assays Stefan SerkeSabine SäsuberlichDieter Huhn Original Article Pages: 45 - 53
Serum levels of interleukin-6 in multiple myeloma and other hematological disorders: correlation with disease activity and other prognostic parameters D. M. NachbaurM. HeroldH. Huber Original Article Pages: 54 - 58
Bone marrow transplantation or chemotherapy as post-remission treatment of adult acute myelogenous leukemia R. WillemzeW. E. FibbeF. E. Zwaan Original Article Pages: 59 - 63
C8 binding protein bears I antigenic determinants P. Blaas-MautnerS. FilsingerG. M. Hänsch Original Article Pages: 64 - 67
Hepatitis C-virus (HCV) antibodies in patients after kidney transplantation P. BaurV. DanielD. Roelcke Original Article Pages: 68 - 73
Anaphylactoid reaction with bronchospasm following intravenous cyclophosphamide administration Gilles SallesThierry VialEric Archimbaud Case Report Pages: 74 - 75
Spontaneous interferon-α antibodies in a patient with pure red cell aplasia and recurrent cutaneous carcinomas O. PrümmerN. FrickhofenF. Porzsolt Case Report Pages: 76 - 80
Intranasal fractionated administration of desamino-D-arginine vasopressin (DDAVP) in patients with Von Willebrand's disease B. GaricocheaE. A. D'AmicoD. A. F. Chamone Letter to the Editor Pages: 81 - 82
GM-CSF therapy and capillary-leak syndrome M. ArningK. O. KlicheW. Schneider Letter to the Editor Pages: 83 - 83
